Medtech Acquisition Corp.-CWTLSIWPreferred / convertible

13F holders, Q4 2025 (December 31)
8holders +4
5new positions
1sold out
1famous investor
$1.65avg. 13F price*

At the end of Q4 2025, 8 institutions reported holding Medtech Acquisition Corp.-CW (TLSIW) in their 13F filings, up 4 from Q3 2025. 5 opened new positions and 1 sold out. The largest holders were Cerity Partners LLC ($1.4M), Citadel Advisors ($129K) and Vestcor Inc ($117K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).

Company
Medtech Acquisition Corp.-CW
Filed as
TRISALUS LIFE SCIENCES INC (Q4 2025)
CUSIP
89680M119
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q1 2024: 21Q1 2024Q2 2024: 19Q2 2024Q3 2024: 8Q3 2024Q4 2024: 8Q4 2024Q1 2025: 6Q1 2025Q2 2025: 5Q2 2025Q3 2025: 4Q3 2025Q4 2025: 8Q4 2025Q1 2026: 7Q1 2026Q2 2026: 5Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions5$1.5M
Exits1$19K

All 13F filers, Q3 2025 → Q4 2025: 914,129 shares bought and 59,593 shares sold, net +854,536 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 8 holders

Cerity Partners LLC — New 827,590 $1.4M
Citadel Advisors — Reduce -38.3% 78,283 $129K
Vestcor Inc — No change 70,832 $117K
Wolverine Asset Management LLC — New 30,990 $51K
Fort Baker Capital Management LP — New 26,474 $44K
Aristeia Capital, L.L.C. — New 28,066 $43K
Toronto Dominion Bank — No change 5,170 $8K
Bank of America Corp. — New 1,009 $2K

"% of holder's portfolio" is TLSIW's weight in each manager's 13F, not the share of Medtech Acquisition Corp.-CW the manager owns.